Impulse Dynamics® Announces New Chief Financial Officer

Company Overview - Impulse Dynamics® is a global medical device company focused on improving the lives of patients with heart failure (HF) [1][6] - The company has developed proprietary CCM® therapy, delivered through the Optimizer® system, which has shown to significantly improve the quality of life for HF patients [5][6] Leadership Appointment - Richard J. Buchholz has been appointed as the new Chief Financial Officer (CFO), effective March 2, 2026 [1] - Buchholz has extensive experience in the medical device industry, previously serving as CFO for Inspire Medical Systems, where he contributed to significant revenue growth and successful IPO [2][3] Financial Growth and Strategy - Under Buchholz's leadership, Inspire Medical Systems saw revenue increase from $3.8 million in 2014 to over $910 million in 2025, highlighting his capability in driving financial success [2] - Impulse Dynamics® recently completed a $158 million financing round aimed at supporting commercialization efforts, advancing product pipelines, and funding clinical trials [4] Clinical Trials and Product Development - The company is advancing clinical trials such as the INTEGRA-D™ and AIM HIGHer trials, which assess the investigational CCM-D® HF System [4] - The INTEGRA-D™ trial aims to provide a breakthrough option for alleviating heart failure symptoms while offering the protection of an implantable cardioverter defibrillator (ICD) [4] Regulatory Developments - The Centers for Medicare and Medicaid Services (CMS) issued a National Coverage Determination (NCD) for CCM® therapy, recognizing its evidence-based outcomes and improving access for HF patients [4]